Yu Lu
Impact in
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 52
- Phenothiazines and Benzothiazines Synthesis and Activities 25
-
- Tuberculosis Research and Epidemiology 63
- Co-authors
- Mingliang Liu (32 shared papers)Lei Fu (36 shared papers)Bin Wang (21 shared papers)Jian Xu (14 shared papers)Haihong Huang (20 shared papers)Kai Lv (22 shared papers)Huiyuan Guo (15 shared papers)Bin Wang (20 shared papers)
- Journals
- European Journal of Medicinal Chemistry (19 papers)Antimicrobial Agents and Chemotherapy (12 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Medicinal Chemistry (7 papers)ACS Medicinal Chemistry Letters (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yu Lu
120 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 1.0k
- Molecular Medicine 174
- Organic Chemistry 762
- Molecular Biology 1.1k
- Epidemiology 479
Countries citing papers authored by Yu Lu
This map shows the geographic impact of Yu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lu more than expected).
Fields of papers citing papers by Yu Lu
This network shows the impact of papers produced by Yu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lu. The network helps show where Yu Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 154 | |
| 2 | 2017 | 113 | |
| 3 | 2014 | 73 | |
| 4 | 2012 | 61 | |
| 5 | 2021 | 60 | |
| 6 | 2017 | 55 | |
| 7 | 2019 | 51 | |
| 8 | 2021 | 45 | |
| 9 | 2022 | 43 | |
| 10 | 2020 | 41 | |
| 11 | 2017 | 40 | |
| 12 | 2018 | 39 | |
| 13 | 2012 | 38 | |
| 14 | 2016 | 38 | |
| 15 | 2017 | 37 | |
| 16 | 2018 | 36 | |
| 17 | 2015 | 35 | |
| 18 | 2014 | 34 | |
| 19 | 2017 | 34 | |
| 20 | 2019 | 33 |
About Yu Lu
Yu Lu is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Organic Chemistry and Molecular Medicine, having authored 124 papers that have together received 2.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (63 papers), Cancer therapeutics and mechanisms (52 papers), Mycobacterium research and diagnosis (26 papers), Phenothiazines and Benzothiazines Synthesis and Activities (25 papers), Quinazolinone synthesis and applications (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers), Synthesis and biological activity (11 papers) and Synthesis and Biological Evaluation (9 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Molecular Medicine (174 citations), Organic Chemistry (762 citations), Molecular Biology (1.1k citations) and Epidemiology (479 citations). Yu Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingliang Liu, Lei Fu, Bin Wang, Jian Xu, Haihong Huang, Kai Lv, Huiyuan Guo, Bin Wang, Apeng Wang and Bin Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.